Skip to content
The Nexus
DossierENTITY

long-term health concerns

Coverage of long-term health concerns in the Nexus archive.

Earliest in view: Jun 14 · 06:28 UTCMost recent: Jun 14 · 06:28 UTC
Co-mentioned in this coverage
Ozempictopic1Wegovytopic1Mounjarotopic1Zepboundtopic1Fitbitorganization1GLP-1 weight loss drugstopic1physical activity declinetopic1muscle mass reductiontopic1
Recent coverage
  • HEALTHJun 14 · 06:28 UTCSCIENCE DAILY
    People taking GLP-1 weight loss drugs like Ozempic started moving less

    People taking GLP-1 weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound may experience reduced physical activity despite weight loss, according to Fitbit data analysis. Researchers noted declines in daily steps and exercise levels, raising concerns about muscle mass loss and long-term health impacts.